RPRX: Royalty Pharma plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 17,299.47
Enterprise Value ($M) 26,973.42
Book Value ($M) 10,141.88
Book Value / Share 23.30
Price / Book 1.71
NCAV ($M) -4,254.59
NCAV / Share -9.77
Price / NCAV -4.07

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.06

Liquidity (mrq)
Quick Ratio 21.95
Current Ratio 21.95

Balance Sheet (mrq) ($M)
Current Assets 2,982.42
Assets 17,378.89
Liabilities 7,237.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,289.00
Operating Income 1,430.00
Net Income 620.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,018.00
Cash from Investing -1,870.00
Cash from Financing 385.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-05 13D/A Giuliani Mario Germano 10.70
02-10 13G/A Morgan Stanley 13.00 21.38
02-10 13G Vanguard Group Inc 6.90
02-10 13G/A Adage Capital Partners Gp, L.l.c. 5.78 -35.83
02-09 13G/A Fmr Llc 5.14 -11.48

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2021-11-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2021-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-05-25 133,805 1,177,893 11.36
2022-05-24 119,362 1,275,822 9.36
2022-05-23 137,977 1,484,192 9.30
2022-05-20 227,745 1,898,128 12.00

(click for more detail)

(click for list of largest short owners)

Similar Companies
RNXT – RenovoRx, Inc. ROIV – Roivant Sciences Ltd
RPHM – Reneo Pharmaceuticals, Inc. RPTX – Repare Therapeutics Inc
RTVA – Artiva Biotherapeutics Inc


Financial data and stock pages provided by
Fintel.io